ReviewTherapeutics and clinical risk management2015

Marketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists' arsenal.

Panagiota Papanagnou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.